4 withdrawn. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 4 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Hearing Loss: new trials by email Literature Review of Hearing Loss trials Research Report on Hearing Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss Dexamethasone, Hyaluronic acid, Indocyanine green(ICG) - Hearing Loss, Sensorineural, Hearing Loss, Sudden | Phase 1 / Phase 2 | Withdrawn | Seoul National University Hospital | 2026-12-15 | 2026-05-22 | |
| Prevention of Noise-induced Hearing Loss Zonisamide, Methylprednisolone - Noise-induced Hearing Loss | Phase 1 / Phase 2 | Withdrawn | Washington University School of Medicine | 2017-10-31 | 2017-11-06 | |
| Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children Autologous Human Umbilical Cord Blood - Hearing Loss | Phase 1 | Withdrawn | Aryn Knight | 2011-04-01 | 2024-03-20 | |
| Protection From Cisplatin Ototoxicity by Lactated Ringers Normal Saline and 0.3% ofloxacin, Lactated Ringer's with 0.03% Ofloxacin - Hearing Loss | Phase 1 | Withdrawn | University of Oklahoma | 2006-07-01 | 2015-05-27 |
Ear Neoplasms (1) · Hearing Loss, Noise-Induced (1) · Hearing Loss, Sensorineural (1) · Hearing Loss, Sudden (1)
Ear Diseases (4) · Hearing Disorders (4) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Otorhinolaryngologic Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Sensation Disorders (4) · Signs and Symptoms (4) · Head and Neck Neoplasms (1) · Hearing Loss, Sensorineural (1) · Neoplasms (1) · Neoplasms by Site (1) · Otorhinolaryngologic Neoplasms (1)
Dexamethasone (1) · Hyaluronic Acid (1) · Indocyanine Green (1) · Methylprednisolone (1) · Methylprednisolone Acetate (1) · Methylprednisolone Hemisuccinate (1) · Ofloxacin (1) · Ringer's Lactate (1) · Saline Solution (1) · Zonisamide (1)
Aryn Knight (1) · Seoul National University Hospital (1) · University of Oklahoma (1) · Washington University School of Medicine (1)
United States (3)
James E. Baumgartner, MD (1) · Judith Lieu, MD (1) · Linda S. Baumgartner, CCC-SLP, LSLS CERT.AVT (1) · Samir Fakhri, MD (1) · Wayne Berryhill, MD (1)